Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clofazamine in the Long Term Treatment of Leprosy, Phase III

Expanded access is no longer available for this treatment.
Sponsor:
Collaborator:
Health Resources and Services Administration (HRSA)
Information provided by (Responsible Party):
Arnold M Henson, MD, Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT00852345
First received: February 26, 2009
Last updated: November 4, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is no longer available for this treatment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given